Tag Archives: research

How to Survive the Patent Cliff: Eli Lilly’s CEO at the BIO CEO & Investor Conference

Fireside Chat

Like a number of companies, Eli Lilly is confronting a wave of patent expirations called the patent cliff. The company lost U.S. patent protection on the anti-psychotic Zyprexa in the fall of 2011 and they’re facing the losses of the antidepressant Cymbalta in December of 2013 and the osteoporosis drug Evista in 2014. The loss of protection endangers the company’s ability to profit from the drugs and they could face a $25 billion loss in Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Poster Session at BIO’s World Congress Showcases Cutting Edge Research

World Congress

BIO’s 10th Annual World Congress on Industrial Biotechnology taking place this June in Montreal will feature a poster session highlighting cutting edge research in industrial biotech. Professors, students, scientists and industry reps are all encouraged to submit posters detailing their research that could lead to the next big breakthrough. Numerous poster submissions have already come in and it’s looking to be a banner year in research. One poster describes a novel pretreatment process using oxalic acid Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Research: Working Together Toward Cures

Jim Greenwood

Modern biomedical innovation and the discovery of new cures and therapies for devastating diseases require robust collaboration and coordination among industry, research institutions and physicians. By bringing together the brightest minds in medical research, our nation’s research enterprise has successfully brought hundreds of new drugs, biologics, and vaccines to market in recent years and developed a wealth of clinical prescribing information. Ongoing research is advancing the fight against some of humanity’s worst scourges, such as Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Case of Misplaced Mountain Magnolias

Magnolia

Amidst the mountains of western North Carolina rests a stand of Sweetbay magnolia trees. This hardly sounds noteworthy, but this story gets interesting. This species of magnolias wouldn’t be easily confused with the much more popular ornamental varieties that are ubiquitous to well manicured southern lawns. Like their popular cousins, these scrawny trees don’t belong in the mountains. They prefer coastal, swampy habitats with wet soils. They are outliers in their present location. So where did Read More >

Food And Agriculture  |  Leave a comment  |  Email This Post
Tags: , ,

“Alz” Well That Ends Well: The Beta-Amyloid Debate in Alzheimer’s Research

alzheimers

Researchers and clinicians alike believe there is substantial evidence to support the hypothesis that Alzheimer’s disease (AD) may be caused by deposition of amyloid beta-peptide (Abeta) in plaques in brain tissue. But drugs targeted towards the beta-amyloid have met with significant setbacks challenging whether the target is, in fact, real. With several late stage drugs targeting beta-amyloid poised for market entry, a panel of opinion leaders in the treatment of Alzheimer’s and scientific industry specialists Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,